Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/BF00208486 http://scihub22266oqcxt.onion/10.1007/BF00208486 8374255!ä!8374255 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\8374255.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Investig 1993 ; 71 (7): 579-84 Nephropedia Template TP {{tp|p=8374255|t=1993. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study |pdf=|usr=}}{{8374255}} gab.com Text Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study JO: Clin Investig http://www.kidney.de/pget.php?&tw=1&pmid=8374255 #FOAvip The effects of long-term therapy (70 days) with torasemide (20 mg/day), a new loop diuretic, were compared with those of furosemide (50 mg/day) in a randomized double-blind trial. Both drugs were administered in association with spironolactone (200 mg/day) in 28 nonazotemic cirrhotic patients with controlled ascites. The treatments did not modify creatinine clearance and exhibited a similar effect on body weight, urinary volume, and fractional excretion of uric acid, sodium, and chloride. The effect of torasemide on fractional potassium excretion was lower than that of furosemide. Torasemide showed higher sparing effect than furosemide on calcium, inorganic phosphate, and magnesium excretion and stronger action on free water clearance. No changes in serum parameters were induced by either treatment. Two episodes of hepatic encephalopathy occurred in the torasemide group. In view of its effects on sodium and water excretion and on other urinary parameters, torasemide can represent an alternative tool for the long-term treatment of ascites. Twit Text FOAVip Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study ????Clin Investig http://www.kidney.de/pget.php?&tw=1&pmid=8374255 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=8374255 #FOAvip English Wikipedia <ref>{{Cite pmid|8374255}}</ref> Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study #MMPMID8374255 Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G Clin Investig 1993[Jul]; 71 (7): 579-84 PMID8374255show ga The effects of long-term therapy (70 days) with torasemide (20 mg/day), a new loop diuretic, were compared with those of furosemide (50 mg/day) in a randomized double-blind trial. Both drugs were administered in association with spironolactone (200 mg/day) in 28 nonazotemic cirrhotic patients with controlled ascites. The treatments did not modify creatinine clearance and exhibited a similar effect on body weight, urinary volume, and fractional excretion of uric acid, sodium, and chloride. The effect of torasemide on fractional potassium excretion was lower than that of furosemide. Torasemide showed higher sparing effect than furosemide on calcium, inorganic phosphate, and magnesium excretion and stronger action on free water clearance. No changes in serum parameters were induced by either treatment. Two episodes of hepatic encephalopathy occurred in the torasemide group. In view of its effects on sodium and water excretion and on other urinary parameters, torasemide can represent an alternative tool for the long-term treatment of ascites. |Ascites/drug therapy/etiology/metabolism[MESH] |Diuretics/metabolism/*therapeutic use[MESH] |Double-Blind Method[MESH] |Drug Therapy, Combination[MESH] |Furosemide/metabolism/*therapeutic use[MESH] |Humans[MESH] |Liver Cirrhosis/*drug therapy/metabolism[MESH] |Spironolactone/therapeutic use[MESH] |Sulfonamides/metabolism/*therapeutic use[MESH]Torasemide versus furosemide in cirrhosis: a long-term, double-blind, (epmc).pdf DeepDyve Pubget Overpricing